Aims & objectives (hypotheses if applicable):
Spinal surgeries often cause severe postoperative pain, delaying recovery
and increasing hospital stays and costs. Lumbar fusion and complex
spinal reconstruction are among the most painful procedures. Incorporating
Multimodal Analgesia (MMA) techniques have become a mainstay therapy followed
by many institutes for all spine surgeries.But its efficacy in Indian
population, especially in tier 2 cities, remains unclear. Further research is
needed to optimize pain management strategies, to pander to the Indian
demography.
Hypotheses- Patients receiving MMA have better postoperative pain scores,
lesser analgesic consumption, stable intraoperative haemodynamics lesser
hospital stay and better patient satisfaction.
4.
Justification for study (whether of national significance with rationale):
Spine surgery is considered to be one of the most painful surgeries, due
to its complexity and extent of surgery. Multimodal Analgesia (MMA) form the
cornerstone of patient care. MMA involves the combined use of various
non-opioid agents and regional techniques to target different pain pathways.
These agents are administered in lower doses at regular intervals to maximize
efficacy while minimizing side effects. These protocols typically
include adding acetaminophen, NSAIDs, gabapentinoids, alpha-2 agonists,
ketamine, and local anaesthetics via infiltration, regional block, or IV routes
along with other routine analgesics agents.
Despite improvements in the understanding of perioperative pain and
incorporation of an MMA protocol across several hospitals in other countries,
the management of postoperative pain in hospitals in tier 2 cities, in India,
still remain suboptimal. Conceptualisation and institutional implementation of
evidence-based MMA regimens into clinical pathways, aim to incorporate best
practice and improve measurable clinical outcomes- including pain, mortality,
hospital length of stay, patient satisfaction and costs.
Moreover, the recent consensus statement for perioperative care in lumbar
spinal fusion from the Enhanced Recovery After Surgery (ERAS) Society along
with the Guidelines From the Society for Neuroscience in Anaesthesiology and
Critical Care (SNACC) recommends use of – Multimodal analgesic strategies such
as- intravenous ketamine, lignocaine and magnesium infusions, along with
neuraxial techniques such as epidural analgesia/intrathecal morphine/
locoregional blocks. This has been proven to reduce opioid consumption, improve
pain control and also reduce duration of hospitalization.
We aim to study whether the same result translates to the Indian
population in a tier 2 city.
5. Departments
involved: Department of Orthopaedics. Department of
Anaesthesia.
.
c) Statistical methods:
Data
will be analysed using IBM SPSS ver. 21.0 (IBM Corp., Armonk, NY, USA).
Categorical data will be represented as frequencies and percentages. Continuous
data will be shown as mean and standard deviation values. Unpaired t-test
(parametric test) will be used as test of significance for continuous, normal
data. Mann-Whitney test (non-parametric test) will be used as test of
significance for continuous, non-normal data. Chi-square test will be used for
testing the significance of difference in categorical data. Bar diagrams and
line diagrams will be made wherever needed. Time trend graph will be utilized to
visualize the rate of change in the VAS score. Inferential analysis will be
performed for numerical data using repeated measures analysis of variance or
other appropriate technique. The p-value will be determined to finally evaluate
the levels of significance. A p-value of LESS THAN 0.05 will be considered as
statistically significant
After obtaining a written informed
consent, all patients will be randomly allocated to either the MMA protocol
group or the routine analgesic protocol group-by block randomisation with a
block size of 4, using computer-generated random sequence table. The
statistician doing the randomisation will be blinded to study and will inform
the group allocation to the Co-Investigator, the day prior surgery via
telephonic communication. The patients will be unaware of the group allocation
and the interventions used, as they will be under anaesthesia. PI will also be blinded to group allocation . Preoperative NRS score and
QoR 15 item score will be assessed by PI.
Preoperatively routine analgesic IV Paracetamol and Tab Gabapetin will be
given 3 hours prior to shifting to OT.
All procedures will be managed by the same anaesthesiologist (Co-
Investigator).
The two groups will be- Multimodal analgesia protocol group (Group A) and
the routine analgesic group (Group B). The consultant surgeon (Principal
Investigator) - who will be doing the case will be collecting postoperative
data, and study subjects, will have no idea regarding the group allocation.
Anaesthesia
technique and perioperative care:
Patient will be
connected to standard ASA monitors like pulse oximetry, continuous
electrocardiogram observation, and non-invasive arterial blood pressure
measurement. For induction of patients received intravenous fentanyl (2 micro g
per kg), fixed dose propofol (1.5-2 mg per kg), and for intubation, vecuronium
(0.1 mg per kg). Temperature monitoring will be established in all patients.
Maintenance will be as per the preference of the anaesthesiologist doing the
case. Muscle relaxation will be with intravenous vecuronium (0.02 mgper kg).
Mechanical ventilation will be achieved with a 50 is to 50 mixture of oxygen
and air (fractional inspired oxygen – 60percent) with adequate tidal volume and
respiratory rate titrated to an end-tidal carbon dioxide between 30 and 35
mmHg. Fluid therapy will be provided according to goal directed fluid therapy
using dynamic monitors. Vasoactive drugs will be administered when necessary to
maintain mean arterial pressure and heart rate within 20percent from baseline.
Intravenous dexamethasone 0.1mg per kg and Intravenous Ondansetron 0.12mg per kg
will be given to counter post-operative nausea and vomiting. If mean arterial
pressure and heart rate is more than 20percent from baseline Intravenous bolus
0.5mcg per kg of fentanyl will be administered. Patients will be placed in
prone position under general anaesthesia.
MMA protocol (Group A):
Analgesic
interventions utilised:
Intraoperatively-
A)
Intravenous Ketamine infusion (bolus 0.5
mg per kg) followed by infusion (0.2-0.3) intraoperatively. This will be stopped after spinal instrumentation
is completed.
B)
After intubation patient will be made lateral, under
Aseptic precautions, the interspinous space above the uppermost level of site
of fusion will be chosen and a 16-gauge Touhy’s needle is advanced till the
loss of resistance (LOR) is felt at the epidural space using LOR technique. Based on number of levels being fused in
lumbar spine surgery, dose of 1.5ml per segment of 0.25 Levobupivacaine, local
anaesthetic solution will be used, will be administered slowly with regular aspiration after each 2 ml of
the solution. It will be given as a single shot epidural injection. The
epidural will be given by anaesthesiologist in lateral position after
intubation, before surgeon comes for case. In the group B only a pin prick will
be made at the required level, to blind the surgeon.
(Group
B).
The above
regimen will not be followed. Instead, a Diclofenac transdermal patch will be placed by
anaesthesiologist after induction of anaesthesia.
At any time
during surgery bolus doses of “rescue dose” Fentanyl 0.5 mcg per kg will be
administered. The total number of bolus doses of rescue fentanyl will be noted.
In both the
groups, anaesthetic agents used- will be tapered and stopped before extubation.
Post surgery, once patient is made supine, residual neuromuscular blockade will
be reversed with Intravenous Neostigmine 50 mcg per kg, Glycopyrrolate 10 mcg
per kg. MAC(Minimum Alveolar Concentration) maintained intraoperatively will be
noted. Time to awakening after switching off all anaesthetic agents, will be
recorded in both the groups. Intraoperative incidence of hypotension and
bradycardia will also be recorded.
All surgeries
were conducted by the same spine surgeon. To avoid possible bias, the Co-PI
will be blinded to the postoperative NRS scores and total analgesic usage.
These will be recorded by the principal investigator (PI).
10. Outcome
measures:
Primary outcomes to be measured:
To Determine
and compare the postoperative pain scores.
Secondary outcomes measured:
Determine and
compare the intraoperative and postoperative analgesic consumption.
intraoperative haemodynamics, incidence of postoperative nausea and vomiting,
time to awakening from anaesthesia, time to postoperative patient mobilization,
length of hospital stay, quality of recovery score and patient satisfaction
score.
11. Potential risks and benefits:
RISKS-
With MMA:
·
Accidental dural puncture during epidural injection- If occurs,
procedure will be abandoned. Bed rest is usually adequate if this complication
were to arise.
·
Postoperative delirium / disorientation due to
ketamine effects. - Unlikely to occur since this study is using subanaesthetic
doses of ketamine. These side effects occur only if infusion is given more than
0.5 mg/kg/hour
With Routine procedure: NIL. Since no new intervention is
being applied.
If
any complications were to occur, which would lead to ICU admission / additional
treatments directly related to above complications- Cost will be covered via
applying to the group insurance.
BENEFITS- The validation of the efficacy of MMA techniques enables
the integration of non-opioid medication, regional techniques and other
minimally invasive modalities into the analgesic framework for complex spine surgeries.
This advancement facilitates the acceptance and incorporation of multimodal
analgesic protocols, especially in the Indian scenario, in tier 2 hospitals.
Consequently, these refinements contribute to optimizing patient recovery and
expediting postoperative rehabilitation. This will be systematically
incorporated into the Enhanced Recovery After Surgery (ERAS) framework for
spine surgeries.
12. Ethical considerations and
methods to address issues:
Written informed consent,
Participant Information sheet will be discussed and shared with participants.
The identity of patients will be confidentia